{
    "clinical_study": {
        "@rank": "132937", 
        "arm_group": [
            {
                "arm_group_label": "T-2345", 
                "arm_group_type": "Experimental", 
                "description": "T-2345 Ophthalmic Solution dosed 1 drop QD in the eye(s) in the evening (8 pm +/- 30 minutes)"
            }, 
            {
                "arm_group_label": "Xalatan", 
                "arm_group_type": "Experimental", 
                "description": "Xalatan (Latanoprost 0.005% Ophthalmic Solution) dosed 1 drop QD in the eye(s) in the evening (8 pm +/- 30 minutes)"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a Phase 3 study to evaluate the safety and efficacy of T-2345 dosed to one of both\n      eyes once daily for 84 days compared to Xalatan dosed to one of both eyes once daily for 84\n      days in patients with elevated eye pressure."
        }, 
        "brief_title": "Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Primary Open Angle Glaucoma", 
            "Ocular Hypertenstion"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle", 
                "Hypertension", 
                "Ocular Hypertension"
            ]
        }, 
        "detailed_description": {
            "textblock": "The objective of this Phase 3 study is to evaluate the efficacy and safety of T-2345\n      nonpreserved ophthalmic solution (latanoprost 0.005%) in comparison to Xalatan\u00ae (latanoprost\n      0.005%) in subjects with primary open angle glaucoma (POAG) or ocular hypertension (OH).\n\n      This will be a randomized, multicenter, parallel-group, observer-masked study in\n      approximately 380 evaluable subjects treated for 84 days. Subjects will have a history of\n      POAG or OH and elevated intraocular pressure (IOP) and will have been adequately controlled\n      (IOP \u2264 18 mm Hg) on latanoprost 0.005% ophthalmic solution monotherapy for at least 4 weeks.\n\n      Primary efficacy (IOP) will be assessed in the study eye at each visit by Goldmann\n      applanation tonometry at all assessment visits.\n\n      Safety will be assessed at each visit by corrected Snellen Visual Acuity, slit lamp\n      examination/anterior chamber cell count and flare and adverse event (AE) collection.\n\n      Primary Efficacy Endpoint is the between-group comparison of the mean IOP values at each\n      time point at each of the Day 15, 42, and 84 visits.\n\n      Secondary Efficacy Endpoints include:\n\n        -  Between-group comparison of the mean change from baseline in diurnal IOP measurements\n           at all postbaseline visits.\n\n        -  Between-group comparison of the mean change from baseline in IOP measurements at all\n           times points at Day 15, Day 42 and Day 84."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Age 18 years or older.\n\n          2. POAG or OH with IOP treated and adequately controlled (IOP \u2264 18 mm Hg) with\n             latanoprost 0.005% ophthalmic solution monotherapy for at least 4 weeks prior to\n             Screening.\n\n          3. Each eye being treated with latanoprost 0.005% ophthalmic solution monotherapy must\n             have mean IOP \u2264 18 mm Hg at Screening and mean IOP \u2264 28 mm Hg at Baseline;\n             measurements will be taken at each visit at 8 AM, 10 AM, and 4 PM (each \u00b1 30 minutes)\n             with AM measurements of IOP at least 2 hours apart. If only one eye qualifies but\n             both eyes have glaucoma and the fellow eye will require antiglaucoma medications, the\n             subject does not qualify for the trial.\n\n          4. Stable visual field (VF), defined as no sign of VF degradation between two\n             consecutive 30-2 or two consecutive 24-2 VF examinations. For subjects with no VF\n             defect (eg, those with OH), a single, normal VF examination performed \u02c2 6 months\n             prior to the screening visit is allowed to determine eligibility. For patients who\n             have an abnormal VF examination, the following criteria apply:\n\n               -  Two VF (most recent VF and past VF) examinations performed at least \u2265 6 months\n                  and \u2264 18 months apart must be compared;\n\n               -  The most recent VF examination should be performed < 6 months prior to the\n                  Screening visit;\n\n               -  The past VF examination should be performed \u2265 6 months and \u2264 18 months prior to\n                  the most recent VF test.\n\n          5. Stable corrected Snellen visual acuity (VA) of better than 20/200 in the study eye.\n             Patients must see \u2265 50% of the letters on a single line to accept that VA line.\n\n          6. Central corneal thickness 480-620 \u03bcm in the study eye.\n\n          7. Shaffer gonioscopic grade of \u2265 3 (in at least 3 quadrants) in both eyes.\n\n          8. Female subjects must be 1-year postmenopausal, surgically sterilized, or women of\n             childbearing potential with a negative urine pregnancy test at Screening. Women of\n             childbearing potential must use an acceptable form of contraception throughout the\n             study. Acceptable methods include the use of at least one of the following:\n             intrauterine (intrauterine device), hormonal (oral, injection, patch, implant, ring),\n             barrier with spermicide (condom, diaphragm), or abstinence.\n\n          9. All subjects must provide signed written consent prior to participation in any\n             study-related procedures.\n\n        Exclusion Criteria:\n\n        In the study eye:\n\n          1. A mean deviation of < -20 dB on VF examination.\n\n          2. A mean IOP \u02c3 28 mm Hg at Baseline.\n\n          3. Presence of a scotoma within 5\u00b0 of fixation on VF examination.\n\n          4. Aphakia.\n\n          5. Use of any antiglaucoma medication in addition to latanoprost 0.005% ophthalmic\n             solution within 2 weeks prior to Screening and any antiglaucoma medication (other\n             than latanoprost) during the study period other than the randomized study medication.\n\n          6. Use of any topical ophthalmic steroid within 2 weeks prior to Baseline. A short\n             course of oral steroids is acceptable if the course is completed > 2 weeks prior to\n             Screening. Inhaled and intranasal steroids are acceptable.\n\n          7. Use of topical nonsteroidal anti-inflammatory drug (NSAID) within 2 weeks prior to\n             Baseline.\n\n          8. Use of any ophthalmic medications during the study period (nonpreserved artificial\n             tears are allowed).\n\n          9. Ocular surgery or laser treatment of any kind in the study eye within 3 months prior\n             to Baseline.\n\n         10. History of ocular allergy/inflammation and/or severe blepharitis and/or uveitis.\n             Seasonal allergic conjunctivitis is acceptable (avoid enrollment of subjects who may\n             experience seasonal flare-up during the study period). Mild\n             blepharitis/blepharoconjunctivitis, typically associated with prostaglandin usage, on\n             the lid is acceptable.\n\n         11. History of ocular trauma or ocular infection within 3 months of Screening.\n\n         12. History of herpes simplex keratitis.\n\n         13. Current proliferative diabetic retinopathy or age-related macular degeneration,\n             unless deemed not clinically significant by the Investigator.\n\n         14. Severe dry eye (eg, clinically relevant superficial punctate keratitis, epithelial\n             erosions of the cornea, and/or use of dry eye medication [including artificial tears]\n             with a frequency exceeding 8 instillations per day).\n\n         15. Contact lens wear during the study period. Contact lens wear in an untreated fellow\n             eye is allowed.\n\n         16. Any secondary glaucoma or OH (eg, congenital glaucoma, closed-angle glaucoma, uveitic\n             glaucoma, or pseudoexfoliation syndrome).\n\n         17. Any severe glaucoma defined by cupping (cup-to-disc ratio \u2265 0.8).\n\n         18. Any non-laser glaucoma surgery.\n\n         19. Any abnormality preventing accurate assessment (eg, resulting in unreliable\n             applanation tonometry or VF examination).\n\n             General:\n\n         20. Pregnancy or lactation.\n\n         21. Uncontrolled asthma (defined as asthma that does not respond to the maximum\n             guideline-directed therapy).\n\n         22. Allergy to benzalkonium chloride.\n\n         23. History of moderate or severe renal or hepatic impairment.\n\n         24. Participation in any study of an investigational product within 30 days prior to\n             Screening or at any time during the study period."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02059278", 
            "org_study_id": "T-2345-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "T-2345", 
                "description": "T-2345 Ophthalmic Solution", 
                "intervention_name": "T-2345", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Xalatan", 
                "description": "Xalatan (latanoprost 0.005% ophthalmic solution)", 
                "intervention_name": "Xalatan", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Latanoprost"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Primary open angle glaucoma", 
            "Ocular hypertenstion"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "location": [
            {
                "contact": {
                    "email": "shauna.pritchett@littlerockeye.com", 
                    "last_name": "Shauna Pritchett", 
                    "phone": "501-712-2516"
                }, 
                "facility": {
                    "address": {
                        "city": "Little Rock", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "72205"
                    }, 
                    "name": "Little Rock Eye Center"
                }, 
                "investigator": {
                    "last_name": "Charles Henry, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sallcindy@yahoo.com", 
                    "last_name": "Cindy Lee", 
                    "phone": "562-804-1974"
                }, 
                "facility": {
                    "address": {
                        "city": "Artesia", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90701"
                    }, 
                    "name": "Sall Research Medical Center"
                }, 
                "investigator": {
                    "last_name": "Ken Sall, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Alewis@northbayeye.com", 
                    "last_name": "Angela Lewis", 
                    "phone": "707-769-2240"
                }, 
                "facility": {
                    "address": {
                        "city": "Petaluma", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94954"
                    }, 
                    "name": "North Bay Eye"
                }, 
                "investigator": {
                    "last_name": "Jason Bacharach, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "elizabeth@glaucdocs.com", 
                    "last_name": "Elizabeth Salinas", 
                    "phone": "303-794-1111"
                }, 
                "facility": {
                    "address": {
                        "city": "Parker", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80134"
                    }, 
                    "name": "Specialty Eye Center"
                }, 
                "investigator": {
                    "last_name": "Charles McMahon, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "clinicaleye@danburyeye.com", 
                    "last_name": "Pat Stenko", 
                    "phone": "203-791-2020"
                }, 
                "facility": {
                    "address": {
                        "city": "Danbury", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06810"
                    }, 
                    "name": "Danbury Eye Physicians and Surgeons"
                }, 
                "investigator": {
                    "last_name": "Paul Matthew, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "cdeschaine@ctispec.com", 
                    "last_name": "Cara Deschaine", 
                    "phone": "203-926-1700"
                }, 
                "facility": {
                    "address": {
                        "city": "Shelton", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06484"
                    }, 
                    "name": "Connecticut Eye Specialists"
                }, 
                "investigator": {
                    "last_name": "Joseph Sokol, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "khagin@theeyeassociates.com", 
                    "last_name": "Karen Hagin", 
                    "phone": "941-792-2020"
                }, 
                "facility": {
                    "address": {
                        "city": "Bradenton", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34209"
                    }, 
                    "name": "The Eye Associates of Manatee"
                }, 
                "investigator": {
                    "last_name": "Robert Friedman, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "michellew@irctampa.com", 
                    "last_name": "Michelle Whidden", 
                    "phone": "813-875-6588"
                }, 
                "facility": {
                    "address": {
                        "city": "Brandon", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33602"
                    }, 
                    "name": "International Research Center"
                }, 
                "investigator": {
                    "last_name": "Bernard Perez, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "carol.hernandoeye@tampabay.rr.com", 
                    "last_name": "Carol Smith", 
                    "phone": "352-596-4030"
                }, 
                "facility": {
                    "address": {
                        "city": "Brooksville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34613"
                    }, 
                    "name": "Hernando Eye Institute"
                }, 
                "investigator": {
                    "last_name": "Leonard Cacioppo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "nsmith@encoredocs.com", 
                    "last_name": "Nina Smith", 
                    "phone": "352-563-1865"
                }, 
                "facility": {
                    "address": {
                        "city": "Crystal River", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "34429"
                    }, 
                    "name": "Nature Coast Clinical Research"
                }, 
                "investigator": {
                    "last_name": "John Rowda, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "helendubiner@hotmail.com", 
                    "last_name": "Helen Dubiner", 
                    "phone": "404-520-1111"
                }, 
                "facility": {
                    "address": {
                        "city": "Morrow", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30260"
                    }, 
                    "name": "Clayton Eye Center"
                }, 
                "investigator": {
                    "last_name": "Harvey Dubiner, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "john@coastalresearchassociates.com", 
                    "last_name": "John Schuhr", 
                    "phone": "770-777-1928"
                }, 
                "facility": {
                    "address": {
                        "city": "Roswell", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30076"
                    }, 
                    "name": "Coastal Research Associates"
                }, 
                "investigator": {
                    "last_name": "Doug Day, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kathyw@thomaseye.com", 
                    "last_name": "Kathy Wynne", 
                    "phone": "404-256-1507"
                }, 
                "facility": {
                    "address": {
                        "city": "Sandy Springs", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30328"
                    }, 
                    "name": "Thomas Eye Group"
                }, 
                "investigator": {
                    "last_name": "Dana Wallace, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "eric.malm@chicagoresearchcenter.com", 
                    "last_name": "Eric Malm", 
                    "phone": "773-282-9845"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60634"
                    }, 
                    "name": "Chicago Research Center"
                }, 
                "investigator": {
                    "last_name": "David Hillman, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "eyeresearch@taustineeyecenter.com", 
                    "last_name": "Bridget Adkins", 
                    "phone": "502-458-9004"
                }, 
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40217"
                    }, 
                    "name": "Taustine Eye Center"
                }, 
                "investigator": {
                    "last_name": "Gregory Sulkowski, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mherrman@greateyecare.com", 
                    "last_name": "Marilyn Herrman", 
                    "phone": "269-428-3300"
                }, 
                "facility": {
                    "address": {
                        "city": "St Joseph", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49085"
                    }, 
                    "name": "Great Lakes Eye Center"
                }, 
                "investigator": {
                    "last_name": "David Cooke, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rzeitzmann@geccobilling.com", 
                    "last_name": "Renee Zeitzmann", 
                    "phone": "636-390-3999"
                }, 
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63090"
                    }, 
                    "name": "Comprehensive Eye Care"
                }, 
                "investigator": {
                    "last_name": "Michael Korenfeld, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mbarnes@kofflervisiongroup.com", 
                    "last_name": "Melissa Barnes", 
                    "phone": "859-263-4631"
                }, 
                "facility": {
                    "address": {
                        "city": "Lexington", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "40509"
                    }, 
                    "name": "Koffler Vision Group"
                }, 
                "investigator": {
                    "last_name": "Bruce Koffler, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "rogstudy@rogeyecare.com", 
                    "last_name": "Mindy VanVoorhis", 
                    "phone": "585-244-6011"
                }, 
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "14618"
                    }, 
                    "name": "Rochester Ophthalmological Group"
                }, 
                "investigator": {
                    "last_name": "Paul Hartman, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "aprice@ceenta.com", 
                    "last_name": "Angela Price", 
                    "phone": "704-295-3390"
                }, 
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28012"
                    }, 
                    "name": "Charlotte Eye Ear Nose and Throat Accociates"
                }, 
                "investigator": {
                    "last_name": "Robert Flores, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "michellemundorf@bellsouth.net", 
                    "last_name": "Michelle Mundorf", 
                    "phone": "704-334-3222"
                }, 
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28204"
                    }, 
                    "name": "Mundorf Eye Center"
                }, 
                "investigator": {
                    "last_name": "Tom Mundorf, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "cindy.wood@cornerstonehealthcare.com", 
                    "last_name": "Cindy Wood", 
                    "phone": "336-802-2255"
                }, 
                "facility": {
                    "address": {
                        "city": "High Point", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27262"
                    }, 
                    "name": "Cornerstone Eye Care"
                }, 
                "investigator": {
                    "last_name": "Michael Tepedino, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Amy.Hoffman@ApexEye.com", 
                    "last_name": "Amy Hoffman", 
                    "phone": "513-561-5655"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45243"
                    }, 
                    "name": "Apex Eye (Madeira)"
                }, 
                "investigator": {
                    "last_name": "Robert Benza, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Barbara.henry@ApexEye.com", 
                    "last_name": "Barbara Henry", 
                    "phone": "513-661-3566"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45238"
                    }, 
                    "name": "Apex Eye (Western Hills)"
                }, 
                "investigator": {
                    "last_name": "Mark Bergmann, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "candace.williams@ApexEye.com", 
                    "last_name": "Candace William", 
                    "phone": "513-745-9787"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45236"
                    }, 
                    "name": "Apex Eye (Kenwood)"
                }, 
                "investigator": {
                    "last_name": "Karen Klugo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "terripruitt@gmail.com", 
                    "last_name": "Terri Pruitt", 
                    "phone": "843-884-1011"
                }, 
                "facility": {
                    "address": {
                        "city": "Mount Pleasant", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29464"
                    }, 
                    "name": "Center for Eye Research"
                }, 
                "investigator": {
                    "last_name": "Elizabeth Sharpe, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "research@chatteye.com", 
                    "last_name": "Tracy Lippard", 
                    "phone": "423-892-3937"
                }, 
                "facility": {
                    "address": {
                        "city": "Chattanooga", 
                        "country": "United States", 
                        "state": "Tennessee", 
                        "zip": "37411"
                    }, 
                    "name": "Chattanooga Eye Institute"
                }, 
                "investigator": {
                    "last_name": "Charles Kirby, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "tcintron@dralpern.com", 
                    "last_name": "Terry Cintron", 
                    "phone": "915-545-2333"
                }, 
                "facility": {
                    "address": {
                        "city": "El Paso", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79902"
                    }, 
                    "name": "The Cataract and Glaucoma Center"
                }, 
                "investigator": {
                    "last_name": "Louis Alpern, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ANITA@rreyes.net", 
                    "last_name": "Anita Holland", 
                    "phone": "210-340-1212"
                }, 
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "R and R Eye Research"
                }, 
                "investigator": {
                    "last_name": "William Flynn, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "EYECLINICS3@SBCGOBAL.NET", 
                    "last_name": "Marcie Smith", 
                    "phone": "210-826-2012"
                }, 
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78209"
                    }, 
                    "name": "Eye Clinics of South Texas"
                }, 
                "investigator": {
                    "last_name": "Jay Rubin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized, Multicenter, Parallel-Group, Observer-Masked, Phase 3 Study to Compare the Safety and Efficacy of T-2345 Ophthalmic Solution to Xalatan (Latanoprost 0.005%) in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension", 
        "overall_contact": {
            "email": "dcoleman@pointguardllc.com", 
            "last_name": "Drey Coleman", 
            "phone": "813-443-0974"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluation of intraocular pressure using Goldmann applanation tonometry.", 
            "measure": "Intraocular pressure", 
            "safety_issue": "No", 
            "time_frame": "84 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02059278"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Corrected Snellen Visual Acuity measurement will be performed at all study visits with the Snellen eye chart using the subject's current corrective lens prescription at a distance equivalent to 20 feet (6 meters)", 
                "measure": "Visual Acuity", 
                "safety_issue": "Yes", 
                "time_frame": "84 days"
            }, 
            {
                "description": "A routine slit lamp examination will be performed in at all study visits to evaluate the anterior segment of the eye, including lids, cornea, conjunctiva, anterior chamber, iris, and lens", 
                "measure": "Slit Lamp Examination", 
                "safety_issue": "Yes", 
                "time_frame": "84 days"
            }, 
            {
                "description": "Direct ophthalmoscopy with dilation will include assessment of the optic nerve head for pallor and cupping. A dilated fundus examination consisting of the vitreous, optic nerve, macula, and peripheral retina will be conducted.", 
                "measure": "Ophthalmoscopy", 
                "safety_issue": "Yes", 
                "time_frame": "84 days"
            }, 
            {
                "description": "The 30-2 or 24-2 test will be performed using an automated perimeter", 
                "measure": "Visual Field Testing", 
                "safety_issue": "Yes", 
                "time_frame": "84 days"
            }, 
            {
                "description": "Adverse events, ocular comfort and tolerability will be assessed throughout the study", 
                "measure": "Safety", 
                "safety_issue": "Yes", 
                "time_frame": "84 days"
            }
        ], 
        "source": "Nephron Pharmaceuticals Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nephron Pharmaceuticals Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}